Cell Study: cMAF Loss in Perivascular Macrophages Opens the Blood-Brain Barrier
Start here
A 2026 Cell study showed that deleting the transcription factor cMAF in perivascular macrophages causes immediate blood-brain barrier leakage. The cMAF-dependent pathway is conserved between humans and mice, which positions perivascular macrophages as a macrophage-lineage platform for the next round of cell therapy competition in neurological disease. The mechanistic finding establishes a direct link between this macrophage population and barrier integrity, but the work so far is basic research; clinical translation and any therapeutic programs built on the pathway have not yet been reported.
Written by a model from the reports · updated 4 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- WeChatPickCell Study Finds cMAF Loss in Perivascular Macrophages Causes Blood-Brain Barrier Leakage
A 2026 Cell study found that deleting cMAF in perivascular macrorophages (PVMs) causes immediate blood-brain barrier leakage. The pathway is conserved between humans and mice, and the article accordingly treats PVMs as the macrophage-lineage platform for the next round of cell therapy competition in neurological disease.
Coverage and heat for this story
Reports so far 1·Heat now 7·Peak heat 10 (Oct 21 15:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.